Cellular senescence enhances adaptive anticancer immunosurveillance

Cancer therapy often induces senescence in some cancer cells. Senescent cells, due to their profoundly altered biology, may conceivably interact with the adaptive immune system in novel ways that may boost cancer immunosurveillance, triggering the clearance of both senescent and non-senescent neopla...

Full description

Saved in:
Bibliographic Details
Main Authors: Ines Marin, Manuel Serrano, Federico Pietrocola
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:OncoImmunology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/2162402X.2022.2154115
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846102296407048192
author Ines Marin
Manuel Serrano
Federico Pietrocola
author_facet Ines Marin
Manuel Serrano
Federico Pietrocola
author_sort Ines Marin
collection DOAJ
description Cancer therapy often induces senescence in some cancer cells. Senescent cells, due to their profoundly altered biology, may conceivably interact with the adaptive immune system in novel ways that may boost cancer immunosurveillance, triggering the clearance of both senescent and non-senescent neoplastic cells. In this regard, we have recently reported that senescent cancer cells exhibit potent antigenicity and adjuvanticity and can elicit strong CD8+ T cell-dependent anticancer effects when used as vaccination agents.
format Article
id doaj-art-a3d0e6213a2a4f6983c3b0cbc39a794b
institution Kabale University
issn 2162-402X
language English
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series OncoImmunology
spelling doaj-art-a3d0e6213a2a4f6983c3b0cbc39a794b2024-12-27T17:34:39ZengTaylor & Francis GroupOncoImmunology2162-402X2023-12-0112110.1080/2162402X.2022.2154115Cellular senescence enhances adaptive anticancer immunosurveillanceInes Marin0Manuel Serrano1Federico Pietrocola2Aging and Metabolism Programme, Institute for Research in Biomedicine (IRB), Barcelona Institute of Science and Technology, Barcelona 08028, SpainAging and Metabolism Programme, Institute for Research in Biomedicine (IRB), Barcelona Institute of Science and Technology, Barcelona 08028, SpainDepartment of Biosciences and Nutrition, Karolinska Institute, Huddinge 14157, SwedenCancer therapy often induces senescence in some cancer cells. Senescent cells, due to their profoundly altered biology, may conceivably interact with the adaptive immune system in novel ways that may boost cancer immunosurveillance, triggering the clearance of both senescent and non-senescent neoplastic cells. In this regard, we have recently reported that senescent cancer cells exhibit potent antigenicity and adjuvanticity and can elicit strong CD8+ T cell-dependent anticancer effects when used as vaccination agents.https://www.tandfonline.com/doi/10.1080/2162402X.2022.2154115Aginginflammationinterferonimmunopeptidomevaccination
spellingShingle Ines Marin
Manuel Serrano
Federico Pietrocola
Cellular senescence enhances adaptive anticancer immunosurveillance
OncoImmunology
Aging
inflammation
interferon
immunopeptidome
vaccination
title Cellular senescence enhances adaptive anticancer immunosurveillance
title_full Cellular senescence enhances adaptive anticancer immunosurveillance
title_fullStr Cellular senescence enhances adaptive anticancer immunosurveillance
title_full_unstemmed Cellular senescence enhances adaptive anticancer immunosurveillance
title_short Cellular senescence enhances adaptive anticancer immunosurveillance
title_sort cellular senescence enhances adaptive anticancer immunosurveillance
topic Aging
inflammation
interferon
immunopeptidome
vaccination
url https://www.tandfonline.com/doi/10.1080/2162402X.2022.2154115
work_keys_str_mv AT inesmarin cellularsenescenceenhancesadaptiveanticancerimmunosurveillance
AT manuelserrano cellularsenescenceenhancesadaptiveanticancerimmunosurveillance
AT federicopietrocola cellularsenescenceenhancesadaptiveanticancerimmunosurveillance